SCHEDULE
PART 3ELIGIBILITY CRITERIA FOR DONORS OF WHOLE BLOOD AND BLOOD COMPONENTS
However, the following deferral periods shall apply for the infections listed in the table:
Brucellosis (*) | 2 years following the date of full recovery |
Osteomyelitis | 2 years after confirmed cured |
Q fever (*) | 2 years following the date of confirmed cure |
Syphilis (*) | 1 year following the date of confirmed cure |
Toxoplasmosis (*) | 6 months following the date of clinical recovery |
Tuberculosis | 2 years following the date of confirmed cure |
Rheumatic fever | 2 years following the date of cessation of symptoms, unless evidence of chronic heart disease |
Fever >38°C | 2 weeks following the date of cessation of symptoms |
Flu-like illness | 2 weeks after cessation of symptoms |
Malaria (*) |
|
— individuals who have lived in a malarial area within the first five years of life | 3 years following return from last visit to any endemic area, provided person remains symptom free; may be reduced to 4 months if an immunologic or molecular genomic test is negative at each donation. |
— individuals with a history of malaria | 3 years following cessation of treatment and absence of symptoms. Donations may be accepted thereafter only if an immunologic or molecular genomic test is negative |
— asymptomic visitors to endemic areas | 6 months after leaving the endemic area unless an immunologic or molecular genomic test is negative |
— individuals with a history of undiagnosed febrile illness during or within six months of a visit to an endemic area | 3 years following resolution of symptoms; may be reduced to 4 months if an immunologic or molecular test is negative |
West Nile Virus (WNV) (*) | 28 days after leaving an area with ongoing transmission of WNV to humans |